Contact this trialFirst, we need to learn more about you.
PI3K Inhibitor
Nab-paclitaxel + Alpelisib for Triple Negative Breast Cancer
Recruiting3 awardsPhase 2
Houston, Texas
This trial is studying nab-paclitaxel and alpelisib to see how well they work in treating triple negative breast cancer that does not respond to anthrocycline chemotherapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.